The DOI matches its Crossref record.
Receptor-effector coupling by G proteins: implications for normal and abnormal signal transduction
Abstract
THE ROLE of heterotrimeric guanine nucleotide binding proteins (G proteins) in signal transduction was first covered in Endocrine Reviews in 1981, when three distinct G proteins involved in visual transduction and regulation of cAMP formation were recognized (1). This topic was updated in Endocrine Reviews in 1989 by which time the number of mammalian G proteins identified had doubled, and their roles in regulation of various phospholipases and ion channels had been recognized (2). Barely 3 years later, the number of distinct mammalian G proteins recognized has again doubled, multiple G proteins have been identified in invertebrates, plants, and single-celled eukaryotes, and the number of cellular functions shown to be regulated by G proteins has increased correspondingly. Numerous excellent reviews covering various aspects of this topic have recently appeared (3–9), but given the rapidity of progress in this field, an update in Endocrine Reviews appears timely. This review summarizes recent progress in our understanding of G protein structure, function, and diversity. Particular emphasis is given to the problem of defining specificity in coupling of receptors to various G proteins, and the involvement of abnormal G proteins in human disease. Two related areas, that of G protein-coupled receptors (10) and of low molecular weight GTP-binding proteins such as the ras p21 protooncogenes (7, 11, 12), have also undergone an explosive increase in information. Detailed consideration of the structure, function, and diversity of both of these important classes of protein beyond the scope of this review, but selected areas will covered as they relate to the heterotrimeric G proteins themselves. Our citation of the extensive literature on G proteins is not comprehensive; instead, we have emphasized more recent references, and in some instances directed the reader to recent reviews for more detailed coverage of a particular area.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Fat cell adrenergic receptors and the control of white and brown fat cell function
Lafontan, M., & Berlan, M. (1993) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37695-1 · Cited by 641
New roles for G-protein (βγ-dimers in transmembrane signalling
Clapham, D. E., & Neer, E. J. (1993) · Nature · doi:10.1038/365403a0 · Cited by 634
Gα15 and Gα16 Couple a Wide Variety of Receptors to Phospholipase C
Offermanns, S., & Simon, M. I. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.25.15175 · Cited by 498
Dopamine receptors: Molecular biology, biochemistry and behavioural aspects
Jackson, D. M., & Westlind-Danielsson, A. (1994) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(94)90041-8 · Cited by 483
Offermanns, S., Laugwitz, K. L., Spicher, K., & Schultz, G. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.2.504 · Cited by 465
Stratakis, C. A., Carney, J. A., Lin, J. P., Papanicolaou, D. A., Karl, M., Kastner, D. L., Pras, E., & Chrousos, G. P. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118467 · Cited by 459
Molecular Basis of Receptor/G-Protein-Coupling Selectivity
Wess, J. (1998) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(98)00030-8 · Cited by 442
Weinstein, L. S., Yu, S., Warner, D. R., & Liu, J. (2001) · Endocrine Reviews · doi:10.1210/edrv.22.5.0439 · Cited by 420
The Significance of Vasoactive Intestinal Peptide in Immunomodulation
Delgado, M., Pozo, D., & Ganea, D. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.2.7 · Cited by 412
Yu, S., Yu, D., Lee, E., Eckhaus, M., Lee, R., Corria, Z., Accili, D., Westphal, H., & Weinstein, L. S. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8715 · Cited by 407
Vascular System Defects and Impaired Cell Chemokinesis as a Result of Gα 13 Deficiency
Offermanns, S., Mancino, V., Revel, J.-P., & Simon, M. I. (1997) · Science · doi:10.1126/science.275.5299.533 · Cited by 338
Signal Transduction Pathways: Molecular Targets for Lithium's Actions
Manji, H. K. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950190013003 · Cited by 328
Alvarez, E., Martínez, M. D., Roncero, I., Chowen, J. A., García‐Cuartero, B., Gispert, J. D., Sanz, C., Vázquez, P., Maldonado, A., De Cáceres, J., et al. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02914.x · Cited by 305
Rapid GDP release from Gsα in patients with gain and loss of endocrine function
Iiri, T., Herzmark, P., Nakamoto, J. M., Van Dop, C., & Bourne, H. R. (1994) · Nature · doi:10.1038/371164a0 · Cited by 295
Towards a muscarinic hypothesis of schizophrenia
Raedler, T. J., Bymaster, F. P., Tandon, R., Copolov, D., & Dean, B. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4001924 · Cited by 291
Wang, G.-R., Zhu, Y., Halushka, P. V., Lincoln, T. M., & Mendelsohn, M. E. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.9.4888 · Cited by 271
Volz, A., Göke, R., Lankat-Buttgereit, B., Fehmann, H.-C., Bode, H. P., & Göke, B. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)01006-z · Cited by 96
G protein-coupled receptor structure and function: the impact of disease-causing mutations
Shenker, A. (1995) · Baillière's Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(95)80519-2 · Cited by 81
Metadata
- Authors
- Spiegel, A. M.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 1992-08-01
- Volume
- 13
- Issue
- 3
- Pages
- 536-565
- ISSN
- 0163-769X (ISSN-L)
- OpenAlex
- W4233221453
- Cited by
- 289
- References
- 0
- FWCI
- 12.60
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.